中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 9
Sep.  2011
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2011  >  27(9): 927-930

Application of medical obturation glue in the treatment of hepatolithiasis with laparoscopic hepatectomy

  • Published Date: 2011-09-20
    Abstract
  • Objective To investigate the application of medical obturation glue in patients with hepatolithiasis who underwent laparoscopic hepatectomy.Methods 84 patients with hepatolithiasis of left lateral lobe underwent laparoscopic hepatectomy.These patients were randomly divided into medical obturation glue group (treatment group) and control group.The patients underwent laparoscopic hepatectomy in both groups.Medical obturation glue and omentum filled, conventional suture techniques were used in hepatic cross section in treatment group and control group respectively.Operation time, characteristics of drainage flow, biliary fistula, drainage duration, postoperative liver function test and hospitalization time were observed in the two groups.Results The length of operation, the increasing amplitude of bilirubin and transaminase, the recovery time of liver function, drainage flow, the red blood cell and hemoglobin count in drainage fluid, extubation time and hospitalization time in trail group were significantly lower than that of control group (P<0.05) .Two mild and five biliary fistula were observed in trail group (4.7%) , while five biliary fistula were seen in the control group (11.9%) including:three serious biliary fistula (7.1%) and one sub-diaphragm abscess.Conclusion The application of medical obturation glue in hepatic cross section of patients undergoing laparoscopic hepatolobectomy for hepatolithiasis, is better than the traditional method, in terms of saving operation time, decreasing liver injury, blood loss, biliary fistula.

     

    • FullText(HTML)
    • References(12)
  • [1]韦杨年, 黄海, 莫世发, 等.精准肝切除在肝胆管结石病的临床应用[J].中国普外基础与临床杂志, 2011, 18 (1) :69-72.
    [2]董家鸿, 冷建军.肝切除断面处理[J].肝胆外科杂志, 2008, 16 (2) :95-96.
    [3]唐磊.复杂性肝胆管结石及狭窄的外科手术分析[J].局解手术学志, 2011, 20 (1) :34-35.
    [4]苗山, 贾元利, 武金虎, 等.完全腹腔镜下肝部分切除治疗体会[J].中华腔镜外科杂志 (电子版) , 2010, 3 (1) :53-55.
    [5]王连新, 蒋辉, 周健, 等.手术切除347例原发性肝癌的临床分析[J].肿瘤, 2010, 30 (12) :1048-1050.
    [6]夏穗生, 田霞, 卢永顺.新一代喷涂型福爱乐医用胶[J].临床外科杂志, 2003, 11 (3) :120-121.
    [7]Sabol F, Vasilenko T, Novotny M, et al.Intradermal runningsuture versus 3MTMVetbondTMTissue adhesive for woundclosure in rodents:a biomechanical and histological study[J].Eur Surg Res, 2010, 45 (3-4) :321-326.
    [8]Bege T, EmunganiaO, Vitton V, et al.An endoscopic strat-egy for management of anastomotic complications from bari-atric surgery:a prospective study[J].Gastrointest Endosc, 2011, 73 (2) :238-244.
    [9]Gonz偄lez HD, Figueras Flip J.Topical hemostatic devices insurgery:between science and Marketing[J].Cir Esp, 2009, 85 (7) :23-28.
    [10]陈建雄, 霍枫, 詹世林.医用生物蛋白胶在胰肠吻合中的应用[J].肝胆胰外科杂志, 2010, 22 (5) :405-406.
    [11]Di Carlo I, Toro A.Sealing all of the resection liver surface tomaximize the adhesive strength of the carrier-bound fibrinsealant[J].Arch Surg, 2011, 146 (2) :239.
    [12]Figueras J, Llado L, Miro M, et al.Application of fibrin gluesealant after hepatectomy does not seem justified:results ofarandomized study in 300 patients[J].Ann Surg, 2007, 24 (5) :536.
    • Relative Articles

  • Relative Articles

    [1]XU Zhen, LIU ShouSheng, TAN Jie, SUN BaoKai, DU ShuiXian, XIN YongNing, XUAN ShiYing. Expression and significance of leptin and adiponectin in serum of patients with nonalcoholic fatty liver disease and coronary heart disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2478-2483. doi: 10.3969/j.issn.1001-5256.2020.11.016
    [2]Wang CuiHua, Yue Yan. Research progress in relationship of leptin and adiponectin with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1351-1354. doi: 10.3969/j.issn.1001-5256.2015.08.045
    [3]Kong Yin, Zhang LingYi. The role of leptin and adiponectin in non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(4): 441-443.
    [4]Zhao ZhengBin, Li JunFeng, Huang ShuangSheng, Zhang LiTing, Chen Hong. The advances of profibrogenic research of leptin and its signaling pathways in hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1106-1108.
    [6]Wang ChunPing, Zhang Ming. Evaluation of leptin receptor Gln223Arg polymorphism in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(3): 194-196.
    [7]Li Mei, Liang YingYin, Lin HongZheng, Xu Ya, Chen SongLin, Liu SiChun. Clinical analysis of 32 cases with alcoholic liver disease and alcohol with drawal syndrome[J]. Journal of Clinical Hepatology, 2007, 23(1): 38-39.
    [8]Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361.
    [9]Li RuiYan, Xiong JinHu. Evaluation of the clinical value of the concentration of leptin in viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 96-97.
    [11]Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42.
    [12]Zheng JiMin, Jiang HuiQing, Lu: XiaoPing, Zhang XiangMei. Measurement of ghrelin leptin levels in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 195-196.
    [13]Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41.
    [14]Wang RuiKe, Liu XiuZhen, Zhang GuYun, Li Hong, Sun ZhaoCui, Zhang JinAn. Monitoring the change of interleukin-6 in the alcoholic liver disease and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(2): 100-101.
    [15]Wang HaiQin, Li JuanJuan. Therapeutic effect of GSH on the treatment of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(6): 355-356.
    [16]Li ChuanFeng, Huang YongCan, Qiu Xiang, Po YunFeng. Clinical analysis of 146 cases of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(3): 157-158.
    [17]Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin, Liu RongHua. The relationship between serum leptin levels and the levels of fibrosis marks in patients with hepatitis B.[J]. Journal of Clinical Hepatology, 2004, 20(2): 85-86.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 6.4 %FULLTEXT: 6.4 %META: 89.6 %META: 89.6 %PDF: 4.0 %PDF: 4.0 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.0 %其他: 5.0 %其他: 0.5 %其他: 0.5 %United States: 0.2 %United States: 0.2 %三亚: 0.2 %三亚: 0.2 %上海: 2.1 %上海: 2.1 %东京: 0.2 %东京: 0.2 %东莞: 0.2 %东莞: 0.2 %北京: 10.4 %北京: 10.4 %南京: 1.2 %南京: 1.2 %南宁: 0.2 %南宁: 0.2 %吉林: 0.2 %吉林: 0.2 %哥伦布: 0.2 %哥伦布: 0.2 %天津: 0.5 %天津: 0.5 %广州: 1.2 %广州: 1.2 %张家口: 2.6 %张家口: 2.6 %悉尼: 0.2 %悉尼: 0.2 %成都: 0.2 %成都: 0.2 %无锡: 0.5 %无锡: 0.5 %武汉: 0.9 %武汉: 0.9 %沈阳: 0.5 %沈阳: 0.5 %泉州: 0.2 %泉州: 0.2 %济南: 0.7 %济南: 0.7 %漯河: 0.2 %漯河: 0.2 %石家庄: 0.5 %石家庄: 0.5 %绍兴: 0.2 %绍兴: 0.2 %芒廷维尤: 34.2 %芒廷维尤: 34.2 %芝加哥: 0.7 %芝加哥: 0.7 %苏州: 0.2 %苏州: 0.2 %莫斯科: 0.9 %莫斯科: 0.9 %西宁: 30.4 %西宁: 30.4 %西安: 0.5 %西安: 0.5 %长春: 1.7 %长春: 1.7 %长沙: 1.4 %长沙: 1.4 %青岛: 0.7 %青岛: 0.7 %其他其他United States三亚上海东京东莞北京南京南宁吉林哥伦布天津广州张家口悉尼成都无锡武汉沈阳泉州济南漯河石家庄绍兴芒廷维尤芝加哥苏州莫斯科西宁西安长春长沙青岛

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3873) PDF downloads(769) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2530]YesterdayPV[4969]TodayIP[896]TodayPV[1441]Online[121]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return